Evaluation of Hemoglobinopathies in Cases of Microcytic Hypochromic Anemia by High-Performance Liquid Chromatography
DOI:
https://doi.org/10.21276/apalm.3421Keywords:
Microcytic hypochromic anemia, Hemoglobinopathies, Peripheral blood film, HPLC, Beta thalassemia, Hemoglobin D-PunjabAbstract
Background: Anemia remains a widespread public health problem with major consequences for human health as well as social and economic development. Although estimates of the prevalence of anemia vary widely and accurate data are often lacking, it can be assumed that significant proportions of young children and women of childbearing age are anemic. Hemoglobinopathies are the most common inherited disorders worldwide. These hereditary disorders are a major public health problem in many parts of the world, including India.
Materials and Methods: The cross-sectional study was conducted over one year on 126 cases of microcytic hypochromic anemia. EDTA samples were analyzed using an automated 3-part cell counter (HORIBA) to obtain hemoglobin values and RBC indices. High-Performance Liquid Chromatography (HPLC) was performed using the HbA2-HbF program of D10 (BIO-RAD), based on the principle of cation exchange chromatography.
Results: Out of 126 cases of microcytic hypochromic anemia, hemoglobinopathy was detected in 42 (33%) cases. The results show Beta thalassemia trait constituted 20 (47.6%) cases, followed by 6 (14.5%) cases of Hemoglobin D-Punjab heterozygous, Beta thalassemia major in 5 (11.9%) cases, Hemoglobin D-Iran heterozygous in 2 (4.8%) cases, HbE heterozygous in 3 (7.1%) cases, Hemoglobin E/β+ thalassemia in 1 (2.4%) case, Hemoglobin S heterozygous in 2 (4.8%) cases, and Hemoglobin S/β+ thalassemia in 3 (7.1%) cases.
Conclusion: Our study revealed a substantial presence of hemoglobinopathies in cases with microcytic hypochromic anemia. Most of the hemoglobinopathies detected were accurately quantified by High-Performance Liquid Chromatography (HPLC), which emerges as an optimal method for the routine screening of hemoglobinopathies. HPLC offers advantages such as rapid and accurate results, along with the detection and quantification of abnormal hemoglobin, compared to other tests.
References
1. Kumar V, Abbas AK, Aster JC. Red Blood cell and bleeding disorders. In: Robbins and Cotran Pathologic Basis of Disease. 10th ed. India: Elsevier; 2021. p. 635-45.
2. WHO Health Organization. Geneva: Health topics [Internet]. 2023 May 1 [cited 2023 Dec 28]. Available from: www.who.int.
3. National Family Health Survey. Anaemia: Mukt Bharat [Internet]. 2022 Mar [cited 2023 Dec 28]. Available from: www.main.mohfw.gov.in.
4. Greer JP, Arber AD, Appelbaum RF, Rodgers GM, Means RT Jr, Dispenzieri A, et al. Disorders of Red Blood Cells. In: Wintrobe’s Clinical Hematology. 14th ed. Wolters Kluwer; 2019. p. 835-48.
5. Jain R, Saxena S. Study of abnormal Hemoglobin variants in patients of anemia using high performance liquid chromatography (HPLC). Trop J Pathol Microbiol. 2019;5(11):925-93.
6. Bain JB, Briggs C. Basic Hematological Techniques. In: Dacie and Lewis Practical Hematology. 12th ed. Elsevier; 2017. p. 31-3.
7. Sehgal S, Khan S, Jetley S, Alvi Y. Evaluation of Abnormal Hemoglobin Variants and Hemoglobinopathies on D-10 analyzer – An Institutional Experience from North India. Online J Health Allied Sci. 2022;21(2):8-10.
8. World Health Organization. Hemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: WHO; 2011.
9. Steinberg HM. Disorders of Hemoglobin. In: Harrison’s Principles of Internal Medicine. 21st ed. India: McGraw Hill; 2022. p. 754-6.
10. Bhokare SB, Phulgirkar PP, Joshi AR, Bindu RS. Spectrum of Hemoglobinopathies by high performance liquid chromatography with special reference to role of HbA2 levels. Int J Res Med Sci. 2016;4(12):5269-76.
11. Raman S, Sahu N, Senapati U. A study of Hemoglobinopathies and Hemoglobin variants using high performance liquid chromatography (HPLC). J Evolution Med Dent Sci. 2017;5(11):842-9.
12. Ghosh N, Chakrabarti I, Goswami BK. Study to assess prevalence of Hemoglobinopathies by HPLC among class IX and X students of a rural block, Darjeeling district, West Bengal. Int J Med. 2018;8(2):71-6.
13. Singh J, Saxena M, Ahmad F, Kumar A, Awasthi S, Dutta S. Spectrum of hemoglobinopathies and thalassemias diagnosed on HPLC. Natl J Lab Med. 2016;5(3):71-5.
14. Joneja U, Gulati G, Florea AD, Gong J. The results of Hemoglobin variant analysis in patients revealing microcytic erythrocytosis on complete blood count. Lab Med. 2018;49(2):147-53.
15. Nayak J, Behera J, Das S, Senapati S, Mohanty S, Samanta S. Detection of Hemoglobinopathies by HPLC in patients with microcytic hypochromic anemia. Int J Pharma Clin Res. 2022;14(7):697-705.
16. Bajaj P, Gupta A. Spectrum of Hemoglobinopathies Diagnosed by High Performance Liquid Chromatography. MVP J Med Sci. 2020;7(2):240-5.
17. Bhagora S, Anand V, Goswami H. Evaluation of hemoglobinopathies in microcytic hypochromic anemia cases. Int J Clin Diagn Pathol. 2021;4(1):17-9.
18. Singh V, Biswas AK, Baranwal AK, Asthana B, Dahiya T. Prevalence of Hemoglobinopathies using high-performance liquid chromatography. Asian J Transfus Sci. 2022;17(1):1-6.
19. Jha R. Distribution of Hemoglobinopathies in patients presenting for electrophoresis and comparison of result with High performance liquid chromatography. J Pathol Nepal. 2015;5(10):850-8.
20. Singh K, Parul, Agarwal R, Rawal M, Kundu PR, Kaur S, et al. Study on Spectrum of Hemoglobinopathies in A Tertiary Care Hospital in Haryana, India. Int J Res Med Sci. 2024;8(1):49-55.
21. Kar BC, Satapathy RK, Kulozik AE, Kulozik M, Sirrs S, Serjeant BE, et al. Sickle cell disease in Orissa state, India. Lancet. 1986;2(8517):1198-201.
22. Kulozik AE, Kar BC, Serjeant GR, Serjeant BE, Weatherall DJ. The molecular basis of alpha thalassemia in India. Its interaction with the sickle cell gene. Blood. 1988;71(2):467-72.
23. Mukherjee MB, Lu CY, Ducrocq R, Gangakhedkar RR, Colah RB, Kadam MD, et al. Effect of alpha-thalassemia on sickle cell anemia linked to the Arab-Indian haplotype in India. Am J Hematol. 1997;55(2):104-9.
24. Tambse M, Vasaikar M, Chavan S. Hemoglobin patterns in sickle cell Hemoglobinopathies. MVP J Med Sci. 2017;3(2):183-8.
25. Saha S, Ghosh S, Basu K, Bhattacharya M. Prevalence of β-hemoglobinopathies in Eastern India and development of a novel formula for carrier detection. J Hematopathol. 2020;13(9):159-64.
26. Makkawi M, Alasmari S, Hawan AA, Shahrani MMA, Dera AA. Hemoglobinopathies: An update on the prevalence trends in Southern Saudi Arabia. Saudi Med J. 2021;42(7):784-9.
27. Mahmoud Z, Elshreif A, Eladab A, Abdelkader E, Ashraf. A Cross-sectional Study of Iron Deficiency Anemia and Hemoglobinopathy Carriers among School Children in Two Different Cities in KSA. Maced J Med Sci. 2022;10(3):193-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Saumya Bindlish, Ruchi Aggarwal, Kulwant Singh, Rajiv Mahendru, Manoj Rawal, Swaran Kaur
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).